ADAMTS4 and chronic kidney disease: Our preliminary results of plasma analysis also confirmed the presence of circulating ADAMTS-4 in CKD patients, being highest in stages 2 and 3, with subsequent disappearance until stage 5, which can fit into the dynamics of the development of the disease.